Pediatric Anticoagulant Studies Need Flexible Patient Enrollment Criteria, FDA Panel Says
Executive Summary
While FDA advisory committee membes urge few restrictions, an agency offical emphasizes the “great heterogeneity within this group of patients” and the need to carefully define the goals of a study.